CD44 and cervical carcinoma: In conclusion, the key observations of the current study provide evidence pertaining to the implication of the LINC00337, miR-145, and KLF5 in cervical cancer, particularly in mediating the maintenance of CSC-like properties of CD44+/CD24low/−SFCs in cervical cancer cells.